دورية أكاديمية

Updated results from AVENANCE: Real-world effectiveness of avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) and analysis of subsequent treatment.

التفاصيل البيبلوغرافية
العنوان: Updated results from AVENANCE: Real-world effectiveness of avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) and analysis of subsequent treatment.
المؤلفون: Barthelemy, Philippe, Loriot, Yohann, Thibault, Constance, Gross-Goupil, Marine, Eymard, Jean Christophe, Voog, Eric, Abraham Jaillon, Christine, Le Moulec, Sylvestre, Chasseray, Matthieu, Gobert, Aurélien, Auberger, Benjamin, Viala, Caroline, Cabart, Mathilde, Kazan, Eyad, Lorgis, Veronique, Hilgers, Werner, Josse, Constant, Lambert, Prisca, Solbes, Marie-Noelle, Flechon, Aude
المصدر: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p561-561, 193p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:0732183X
DOI:10.1200/JCO.2024.42.4_suppl.561